Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 487  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
  » Next article
  » Previous article 
  » Table of Contents
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (257 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

  In this Article
 »  Abstract
 »  Introduction
 »  Case report
 »  Discussion
 »  References

 Article Access Statistics
    PDF Downloaded441    
    Comments [Add]    
    Cited by others 33    

Recommend this journal

Year : 2002  |  Volume : 50  |  Issue : 1  |  Page : 75-80

Primary intraspinal primitive neuroectodermal tumor (PNET) : a rare occurrence.

Department of Neurosurgery, Jaslok Hospital and Research Centre, Mumbai, 400026, India.

Correspondence Address:
Department of Neurosurgery, Jaslok Hospital and Research Centre, Mumbai, 400026, India.
[email protected]

  »  Abstract

The concept of primitive neuroectodermal tumors (PNETs) has been evolving for many years, as has been its nomenclature. A 5 year old boy presented with pain in lower cervicodorsal region and left leg. Preoperative MRI of the spine and paravertebral region revealed a hyperintense lobulated lesion extending from D1-D4 with a large intraspinal and thoracic component. A total removal of tumor was achieved via a dorsal laminectomy and right posterolateral thoracotomy. The pathological findings were consistent with PNET. Post operative neurological examination had been unremarkable. Six months follow up scan showed no recurrence. A review of the literature shows that only 18 cases of primary intraspinal PNETs have been reported to date and the present case is exclusive, in which the tumor was thoracic, extradural in location and the child is alive at 8 months of follow up, with no evidence of tumor recurrence/metastasis. Primary intraspinal PNETs are rare tumors and carry a poor prognosis. Newer modalities of treatment should be tried to improve survival.

How to cite this article:
Virani M J, Jain S. Primary intraspinal primitive neuroectodermal tumor (PNET) : a rare occurrence. Neurol India 2002;50:75-80

How to cite this URL:
Virani M J, Jain S. Primary intraspinal primitive neuroectodermal tumor (PNET) : a rare occurrence. Neurol India [serial online] 2002 [cited 2022 Jan 26];50:75-80. Available from:

   »   Introduction Top

Primary neuroectodermal tumor (PNET), a term proposed by Hart and Earle defines a group of malignant neoplasms of presumed neural crest origin.[1] Cases of PNET have been increasingly reported in recent years but there are still very few reports of PNET originating in the spinal cord.
To date, only 18 cases of primary intraspinal PNETs have been reported in the literature. The clinical and pathological features of PNET, its management, and perspectives for the future, with reference to a case of PNET of the spinal cord, are discussed.

   »   Case report Top

A previously healthy 5 year old male child presented with complaints of lower cervico-dorsal pain, breathlessness on exertion, pain in left leg, lassitude, lethargy of one month duration. Family history was unremarkable. There was no history of sphincteric disturbances, weight loss and gait disturbances. On examination, vital parameters were normal. Minimal thoracic scoliosis to right was observed. Neurological examination was unremarkable except for the unsteady gait and tendency to sway to right side. Finger-nose and toe-heel tests were normal.
Radiographic investigations : X-ray chest revealed a heterogeneous soft tissue shadow in right upper zone and right paraspinal region with a smooth convex borders with apparent widening of right 3rd intercostal space posteriorly. Pneumonic consolidation or posterior mediastinal mass were considered as possibilities. MRI of the spine and paravertebral region revealed a hyperintense lobulated lesion in paravertebral region extending from D1-D4 with a large intraspinal and thoracic component. Spinal cord was pushed completely to the left by the lesion [Figure - 1].
Operation : In view of MRI appearance of the tumor hemilaminectomy from C7 to D1 on right side was performed along with right posterolateral thoracotomy. The tumor was extradural in origin and was compressing the cord. Following surgery intercostal tube was inserted to prevent pneumothorax. Postsurgery good chest expansion was noted. Gross total removal of the tumor was performed under the operating microscope.
Pathological findings : Tissue specimen represented a focally necrotic undifferentiated malignant tumor consisting of small round cells exhibiting little or no cytoplasm and rounded smooth contoured vesicular or dense hyperchromatic actively mitotic nuclei. Cells were arranged in compact pattern. No well-defined Homer-Wright or ependymal rosettes were noted [Figure - 2]. Immunohistochemistry was performed using the primary antibodies : synoptophysin, (Dako corp.), LCA and Cytokeratin. Tumor cells showed granular immunostaining in the cytoplasmic rim with synoptophysin. Cytokeratin, LCA were absent in the tumor. Electron microscopy confirmed the presence of poorly differentiated small round cells.The diagnosis of a PNET was arrived at after histological examination, immunohistochemistry and electron microscopy.
Postoperative course : Postoperative course had been uneventful. CT scan brain was normal. Post surgery neurological status showed a slightly weak right grip, unsteady gait which improved with gait training and physiotherapy. A thoracic chin occiput brace was provided. Following surgical recovery, radiation therapy was given in the form of involved field irradiation (IFI) for a period of 8 weeks. MRI at the conclusion of radiotherapy failed to reveal any recurrence or metastasis [Figure - 3]. Currently, eight months after surgery he was asymptomatic, walked unsupported, and had no neurological deficits.

   »   Discussion Top

PNETs are rapidly growing tumors with a brief duration of symptoms and a rapidly progressive course.[1] The tumors encountered are difficult to classify.[2] It was first described as a tumor arising in peripheral nerve, and was called neuroepithelioma.[3]
Hart and Earle first introduced the term primitive neuroectodermal tumor in 1973 to describe predominantly undifferentiated tumors of the cerebrum (with 90-95% of the cells being undifferentiated) that did not fulfill the diagnostic criteria for neuroblastoma, ependymoblastoma, polar spongioblastoma, medulloepithellioma or pineal parenchyma tumors. All neoplasm showing primitive poorly differentiated neuroepithelial cellls can be called primitive neuroectodermal tumors, regardless of location or cell type.[2],[5] Relationship of PNETs and other central nervous system neoplasms is shown in [Figure - 4]. In 1983, Rorke[6] and Becker and Hinton[7] independently reviewed this concept and published separate articles advocating that all central nervous system tumors predominantly composed of primitive neuroepithelial cells be called PNETs. They then further subclassified these tumors based on differentiation. This concept has been widely accepted, although it is still controversial. The most recent classification by world health organization tries to avoid this controversy by grouping these tumors under the category of 'embryonal tumors' with PNET used as a generic term for cerebellar medullo-blastomas.[8]

PNETs most commonly occur in the cerebellum (medulloblastoms) but can arise in the pineal gland, cerebrum, spinal cord brain stem, and peripheral nerves.[9] Primitive neuroectodermal tumors frequently metastasize via the CSF pathways to the spinal and cranial subarachnoid spaces and are highly malignant both histologically and clinically.[10] Standard therapy for the PNET currently consists of gross total resection followed by craniospinal irradiation. Radiation is associated with a higher incidence of intellectual impairment endocrinological disturbances, and growth retardation in young children and results in 5 year survival rates of only 40% to 60%. Chemotherapy is the sole form of therapy used in children under two years of age, because of severe side effects of irradiation in this age group.[10] Because surgery, irradiation and chemotherapy do not adequately treat PNET additional treatment modalities need to be explored.
The 18 previously reported cases along with present case are summarized in [Table I]. In most of these cases, efforts were made to exclude primary intracranial lesions either by imaging and/or autopsy. In present case, the extradural location makes it unlikely that this is a drop metastasis. Morever, CT scan of head failed to reveal any intracranial tumor. This case therefore appears to be exclusive and represents a primary thoracic spinal cord PNET, as neither cerebral nor cerebellar intra-axial lesion, nor peripheral neuroblatomas were seen.
A review of literature shows that primary intraspinal PNETs may arise at all levels of the spine and can be intramedullary, intra -and extramedullary, extramedullary or extradural. It has been postulated that PNETs arise from neoplastic transformation of primitive neuroepithelial cells in subependymal zones.[6] The clinical characteristics of spinal PNETs in the cases described so far including ours [Table I] appear to be:- i) more common in adults rather than children. 12 out of 19 cases being adults, ii) males were predominnantly affected, iii) some of the reported cases had metastasis outside neuraxis with the most frequent sites being lung, bones and lymphnodes, a tendency shared by intracranial PNETs,[2],[11],[14] iv) most of the patients were treated with a combination of surgery, radiotherapy and chemotherapy, but despite treatment most patients did not do well, v) extremely short duration of symptoms favour rapidly growing nature of these tumors, vi) the aggressive nature of the tumor is evidenced by rapid recurrence of the tumor in most of the reported patients. The cause of death in these patients included pneumonia,[12] metastatic disease,[14] aggressive local spread of the diseased,[18] and progressive spinal cord involvement.[16] vii) the tumor was frequently located at lower spinal levels : cervical in four cases, thoracic in two, thoracolumbar in four, lumbar/lumbosacral in 7 cases. viii) as expected in rapidly growing tumors such as these, the survival is less than 2 years. Less than 40% of these patients were alive 2 year after diagnosis, about 10% at 3 year [Figure - 5]. Therefore, need for newer therapeutic modality to improve the survival in these cases.
PET with '8F-fluoro-2-deoxy-glucose (FDG) is an effective imaging modality for evaluating suspected tumor recurrence. Use of FDG PET imaging for spinal cord neoplasms has not yet been studied, mainly due to limitations of spatial resolution. Cidis et al[22] demonstrated the role of FDG PET imaging in recurrent intramedullary PNET affecting the cervical spinal cord.
Adoptive immunotherapy is currently being investigated as a possible therapy. Lymphokine activated killer cells possess several attributes that could make them useful in adoptive immunotherapy. They are highly potent against tumors, require no prior antigen exposure to express their oncolytic effect. Their recognition mechanism is able to distinguish between normal and malignant cells and thereby spare normal tissue and they express oncolytic activity against many tumour types.[10] This study was under taken by Richard et al[10] to determine the potential sensitivity to the tumor cells derived from PNET. The results presented in this study support an adoptive immunotherapeutic approach, consisting of intrathecal administration of IL-2 and LAK cells as an adjuvant to the treatment of PNET. This form of therapy could eradicate residual tumour without the harmful side effects that radiation or chemotherapy produce. The optimal therapy for PNET is uncertain. Early onset of chemotherapy[17],[23] in conjunction with radiation therapy may improve the survival time. However the prognosis of this disease is very poor and most patients develop local recurrence.
As regard to new treatment strategies are concerned, role of peripheral blood stem cell transfusion (PBSCT) is suggested in chemosensitive tumors or in cases where the patient has remissions. PBSCT after remissions prevents relapse. A trial has been conducted at Hinduja hospital, Mumbai, India, where PBSCT was employed in 21 year old male with PNET of chest wall-stage-IV. More studies are required to explore the role of PBSCT in improving the survival
in these patients.[24] Based on this review, we conclude that future advances in the treatment of PNETs must lie with chemotherapy and immunotherapy especially for those patients presenting with disseminated disease. This, combined with early detection, tumor identification and surgical removal and aggressive neuraxis radiation, offers hope of long term and good quality survival. It is fascinating that a tumor which may be of embryonic origin can remain latent and become manifest many years later, suggesting differences in biology involving the tumor itself or the host.


  »   References Top

1.Barbara J : Crain. Primitive neuroectodermal tumours. In : Neurosurgery by Rengachary, Robert H. Wilkins 1996; Vol. II : 1707-1713.   Back to cited text no. 1    
2.Edward J kosnik, Carl Boesel, Janet Bay et al : Primitive neuroectodermal tumours of the central nervous system in the children. J Neurosurg 1978; 48 : 741-746.   Back to cited text no. 2    
3.Von Schlippe M, Whelan JS et al : Primitive neuroectodermal tumour of the chest wall. Ann Oncol 1995; 6/4:395-401.   Back to cited text no. 3    
4.Hart MN, Earle KM : Primitive neuroectodermal tumours of the brain in children. Cancer 1973; 32 : 890-897.   Back to cited text no. 4    
5.Vincent T, De Vita, Jr Samuel Hellman : Neoplasms of the central nervous system. In : Cancer-Principles and practice of oncology. 1997; 5 : 2059-2060.   Back to cited text no. 5    
6.Rorke LB : The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumours. J Neuropath Exp Neurol 1983; 42 : 1-15.   Back to cited text no. 6    
7.Backer A, Mount S L, Zarka MA et al Desmoplastic round cell primary tumour of unknown origin with lymph nodes and lung metastases : Histological, cytological, ultrastructural, cytogenetic and molecular findings. In Virchows Arch.432/2 (135-141); 1998.   Back to cited text no. 7    
8.Kielhuer P, Bueger PC, Scheithauer BW : The new WHO classification of brain tumours. Brain Pathol 1993; 3 : 255-268.   Back to cited text no. 8    
9.Srikanth Deme, Lee-cyn, Ghassan S et al : Primary intramedullary primitive neuroectodermal tumour of the spinal cord : case report and review of the literature Neurosurgery 1997; 41 : 1417-1420.   Back to cited text no. 9    
10.Richard, William, Richard Moser et al : Invitro cytolysis of primitive neuroectodermal tumours of the posterior fossa (medulloblastoma) by lymphokine activated killer cells. J Neurosurg 1988; 60 : 403-409.   Back to cited text no. 10    
11.Smith DR, Hardman JM, Earle KM et al : Metastasizing neuroectodermal tumours of the central nervous system. J Neurosurg1969; 31 : 50-58.   Back to cited text no. 11    
12.Kepes JJ, Belton K, Roessmann U et al : Primitive neuroectodermal tumours of the cauda equina in adults with no detectable primary intracranial neoplasm : Three case studies. Clin Neuropathol 1985; 4 : 1-11.   Back to cited text no. 12    
13.Liu HM, Yang WC, Garcia RL et al : Intraspinal primitive neuroectodermal tumour arising from the sacral neve root. J Comput Tomogr 1987; 11 : 350-354.   Back to cited text no. 13    
14.Sevick RJ, Johns RD, Curry BJ et al : Primary spinal neuroectodermal tumour with extraneural metastasis. AJNR 1987; 8 : 1151-1152.   Back to cited text no. 14    
15.Jakshe H, Wockel W, Wernert N : Primary spinal medulloblastomas? Neurosurg Rev1988; 11 : 259-265.   Back to cited text no. 15    
16.Freyer DR, Hutchinson RJ, McKeever PE : Primary primitive neuroectodermal tumour of the spinal cord associated with neural tube defect. Pediatric Neurosci1989; 15 : 181-187.   Back to cited text no. 16    
17.Ogaswara H, Kiva K, Kurisu K et al : Intracranial metastasis from a spinal cord primitive neuroectodermal tumour : case report. Surg Neurol 1992; 37 : 307-312.   Back to cited text no. 17    
18.McDermott VG, El-Jabbour, Sellar RJ et al : Primitive neuroectodermal tumour of the cauda equina. Neuroradiology1994; 36 : 228-230.   Back to cited text no. 18    
19.Kwon OK, Wang KC, Ki IO et al : Primary intramedullary spinal cord primitive neuroectodermal tumour with intracranial seeding in an infant. Child's Nerv Syst 1996; 12 : 633-636.   Back to cited text no. 19    
20.Koot RW, Henneveld H, Albrecht K et al : Two children with unusual causes of torticollis: Primitive neuroectoddermal tumour and Grisel's syndrome. Ned Tijdschr Geneeskd 1998; 142 : 1030-1033.   Back to cited text no. 20    
21.Rodriguez ku RJ, Trejo Castillo W, Rodriguez ML et al : Spinal primitive neuroectodermal tumour. Gac Med Mex 1999; 135 : 183-188.   Back to cited text no. 21    
22.Cidis C, David M,Townsend W et al : FDG imaging of spinal cord primitive neuroectodermal tumour. J Nucl Med1998; 39 : 1207-1209.   Back to cited text no. 22    
23.Rivera-Luna R, Gomez R, Leal C et al : Is the ancillary chemotherapy approach of any value in the treatment of infratentorial primitive neuroectodermal tumours with surgery and radiotherapy? Child's Nerv Syst 1998; 14 : 109-112.   Back to cited text no. 23    
24.Soumya V : Hinduja successfully performs its first PBSCT. In : Express Healthcare Management 2000; 1 : 3.   Back to cited text no. 24    


Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow